NanoVibronix (NAOV) Revenue & Revenue Breakdown
NanoVibronix Revenue Highlights
Latest Revenue (Y)
$2.28M
Latest Revenue (Q)
$817.00K
Main Geography (Y)
UNITED STATES
NanoVibronix Revenue by Period
NanoVibronix Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.28M | 203.59% |
| 2022-12-31 | $752.00K | -55.63% |
| 2021-12-31 | $1.70M | 172.07% |
| 2020-12-31 | $623.00K | 17.55% |
| 2019-12-31 | $530.00K | 66.67% |
| 2018-12-31 | $318.00K | 33.05% |
| 2017-12-31 | $239.00K | 4.37% |
| 2016-12-31 | $229.00K | 55.78% |
| 2015-12-31 | $147.00K | -27.59% |
| 2014-12-31 | $203.00K | -3.79% |
| 2013-12-31 | $211.00K | 27.11% |
| 2012-12-31 | $166.00K | 76.60% |
| 2011-12-31 | $94.00K | - |
NanoVibronix generated $2.28M in revenue during NA 2023, up 203.59% compared to the previous quarter, and up 717.92% compared to the same period a year ago.
NanoVibronix Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $817.00K | -11.29% |
| 2024-03-31 | $921.00K | -21.75% |
| 2023-12-31 | $1.18M | 156.99% |
| 2023-09-30 | $458.00K | 55.78% |
| 2023-06-30 | $294.00K | -16.95% |
| 2023-03-31 | $354.00K | -447.06% |
| 2022-12-31 | $-102.00K | -205.15% |
| 2022-09-30 | $97.00K | -80.00% |
| 2022-06-30 | $485.00K | 78.31% |
| 2022-03-31 | $272.00K | -64.90% |
| 2021-12-31 | $775.00K | 55.31% |
| 2021-09-30 | $499.00K | 56.92% |
| 2021-06-30 | $318.00K | 208.74% |
| 2021-03-31 | $103.00K | 14.44% |
| 2020-12-31 | $90.00K | -40.00% |
| 2020-09-30 | $150.00K | -44.24% |
| 2020-06-30 | $269.00K | 135.96% |
| 2020-03-31 | $114.00K | 31.03% |
| 2019-12-31 | $87.00K | -13.86% |
| 2019-09-30 | $101.00K | -61.60% |
| 2019-06-30 | $263.00K | 232.91% |
| 2019-03-31 | $79.00K | 46.30% |
| 2018-12-31 | $54.00K | - |
| 2018-09-30 | $54.00K | -59.09% |
| 2018-06-30 | $132.00K | 71.43% |
| 2018-03-31 | $77.00K | 10.00% |
| 2017-12-31 | $70.00K | 7.69% |
| 2017-09-30 | $65.00K | 25.00% |
| 2017-06-30 | $52.00K | - |
| 2017-03-31 | $52.00K | 6.12% |
| 2016-12-31 | $49.00K | -19.67% |
| 2016-09-30 | $61.00K | -1.61% |
| 2016-06-30 | $62.00K | 8.77% |
| 2016-03-31 | $57.00K | 46.15% |
| 2015-12-31 | $39.00K | -2.50% |
| 2015-09-30 | $40.00K | 2.56% |
| 2015-06-30 | $39.00K | 34.48% |
| 2015-03-31 | $29.00K | -44.23% |
| 2014-12-31 | $52.00K | 108.00% |
| 2014-09-30 | $25.00K | -60.94% |
| 2014-06-30 | $64.00K | 3.23% |
| 2014-03-31 | $62.00K | 675.00% |
| 2013-12-31 | $8.00K | -84.00% |
| 2013-09-30 | $50.00K | 47.06% |
| 2013-03-31 | $34.00K | -40.35% |
| 2012-12-31 | $57.00K | 42.50% |
| 2012-09-30 | $40.00K | - |
NanoVibronix generated $817.00K in revenue during Q2 2024, up -11.29% compared to the previous quarter, and up 230.79% compared to the same period a year ago.
NanoVibronix Revenue Breakdown
NanoVibronix Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| UNITED STATES | $2.16B | $710.00K | $1.63M | - | - |
| AUSTRALIA | $19.00M | $9.00K | - | - | - |
| Europe | $101.00M | $25.00K | $18.00K | $147.00K | $168.00K |
| ISRAEL | $1.00M | $5.00K | - | - | - |
| INDIA | - | $3.00K | - | - | - |
| Other Country | - | $5.00K | - | - | - |
| Other country | - | - | $45.00K | - | - |
| India | - | - | - | $1.00K | $12.00K |
| United States | - | - | - | $467.00K | $331.00K |
| Other | - | - | - | $5.00K | $5.00K |
| Israel | - | - | - | $3.00K | $14.00K |
NanoVibronix's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (94.70%), Europe (4.42%), AUSTRALIA (0.83%), and ISRAEL (0.04%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $794.00K | $905.00M | $2.16B | $445.00K | $282.00K | $309.00K | $-118.00K | $90.00K | $476.00K | $231.00K | $753.00K | $490.00K | $292.00K | - | - | - | - | - | - | - |
| Other | $15.00K | $23.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| AUSTRALIA | $8.00K | $4.00M | $18.98M | $2.00K | $13.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Country | - | $12.00M | $11.00K | $12.00K | $12.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Europe | - | - | $100.98M | $19.00K | $12.00K | $6.00K | $7.00K | $3.00K | $4.00K | $10.00K | $1.00K | $10.00K | $17.00K | $3.00K | - | $151.00K | $10.00K | - | - | - |
| Asia | - | - | - | - | - | $1.00K | $1.00K | $9.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| NEW ZEALAND | - | - | - | - | - | - | - | $1.00K | $3.00K | $2.00K | $3.00K | $3.00K | - | - | - | - | - | - | - | - |
| ISRAEL | - | - | - | - | - | - | - | - | - | - | $1.00K | $2.00K | $1.00K | - | - | - | - | - | - | - |
| CANADA | - | - | - | - | - | - | - | - | - | - | - | - | $12.00K | - | - | - | - | - | - | - |
| New Zealand | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.00K | - | - | - | - | - | - |
| United States | - | - | - | - | - | - | - | - | - | - | - | - | - | $92.00K | $76.00K | $130.00K | $110.00K | $101.00K | $90.00K | $68.00K |
| Israel | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.00K | - | $1.00K | $1.00K | - | $12.00K | $1.00K |
| India | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.00K | $2.00K | $8.00K | - | - | - |
| Canada | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Canada 21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.00K | - |
NanoVibronix's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (97.18%), Other (1.84%), and AUSTRALIA (0.98%).
NanoVibronix Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
| RPID | Rapid Micro Biosystems | $22.52M | $6.62M |
| HSCS | Heart Test Laboratories | $18.60M | $14.70K |
| VVOS | Vivos Therapeutics | $13.80M | $4.05M |
| NUWE | Nuwellis | $8.86M | $2.19M |
| RSLS | ReShape Lifesciences | $8.68M | $1.97M |
| SINT | Sintx | $2.63M | $687.00K |
| NAOV | NanoVibronix | $2.28M | $817.00K |
| TIVC | Tivic Health Systems | $1.18M | $140.00K |
| BJDX | Bluejay Diagnostics | - | - |
| BBLG | Bone Biologics | - | - |
| BMRA | Biomerica | - | $1.02M |
NAOV Revenue FAQ
What is NanoVibronix’s yearly revenue?
NanoVibronix's yearly revenue for 2023 was $2.28M, representing an increase of 203.59% compared to 2022. The company's yearly revenue for 2022 was $752K, representing a decrease of -55.63% compared to 2021. NAOV's yearly revenue for 2021 was $1.7M, representing an increase of 172.07% compared to 2020.
What is NanoVibronix’s quarterly revenue?
NanoVibronix's quarterly revenue for Q2 2024 was $817K, a -11.29% decrease from the previous quarter (Q1 2024), and a 177.89% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $921K, a -21.75% decrease from the previous quarter (Q4 2023), and a 160.17% increase year-over-year (Q1 2023). NAOV's quarterly revenue for Q4 2023 was $1.18M, a 156.99% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is NanoVibronix’s revenue growth rate?
NanoVibronix's revenue growth rate for the last 3 years (2021-2023) was 34.69%, and for the last 5 years (2019-2023) was 330.75%.